Our Story

Our Story

BluePrint Research Group was founded in 2008 by three senior market research professionals with 25 years of combined industry experience in firms such as Bristol Myers Squibb, Schering Plough & Vertex.

BluePrint consults with healthcare companies to inform global brand commercialization efforts for the industry’s most innovative medicines, impacting and improving global health and wellness.

years of experience

employees

%

of our work is global

engagements / year

pharmaceutical clients

global offices

Our client-side perspective allows us an intimate picture of what it takes to bring a new product through clinical and commercial development, and has earned us the credibility to interact closely with numerous internal stakeholders. We leverage this experience to drive collaboration and alignment across cross-functional teams when it comes to research insights and resulting decisions.

Our client testimonials emphasize our thought partnership, more often working on longer-term engagements that allow us to help shape strategic imperatives, integrate and synthesize key insights, design and lead workshops to facilitate discussion and decision making specific to commercial strategy.

Our Growth

Our Growth

scroll to explore down-arrow

Over the past 11 years, we have built our firm to 90+ employees, across 6 global office locations, and partner with 50 large, midsize, and early stage biopharmaceutical clients per year. We have relationships with 10 of the top 15 global pharmaceutical companies. More than 60% of our work is global, including western and eastern Europe, Latin America, Canada, Asia Pacific, and the Middle East.

As a company, we execute 275+ engagements per year across a wide breadth of therapeutic areas and a variety of stakeholders.

Our firm’s success and growth has been driven organically, without a business development team or department. Our best business development tool is our impact through partnership and the quality of our next engagement.

Our firm has been growing each year since inception across all key metrics, including employees (25 new consulting team members in 19’), geographies (5th office in Boston/Cambridge this Spring and a 6th office in Philadelphia later in 19’), and clients/revenues.

map-image

Over the past 11 years, we have built our firm to 90+ employees, across 6 global office locations, and partner with 50 large, midsize, and early stage biopharmaceutical clients per year. We have relationships with 10 of the top 15 global pharmaceutical companies. More than 60% of our work is global, including western and eastern Europe, Latin America, Canada, Asia Pacific, and the Middle East.

As a company, we execute 275+ engagements per year across a wide breadth of therapeutic areas and a variety of stakeholders.

Our firm’s success and growth has been driven organically, without a business development team or department. Our best business development tool is our impact through partnership and the quality of our next engagement.

Our firm has been growing each year since inception across all key metrics, including employees (25 new consulting team members in 19’), geographies (5th office in Boston/Cambridge this Spring and a 6th office in Philadelphia later in 19’), and clients/revenues.